Retracted : Long noncoding RNA HAGLROS regulates apoptosis and autophagy in colorectal cancer cells via sponging miR‐100 to target ATG5 expression

The aim of this study was to explore the relationship between the expression of HOXD antisense growth‐associated long noncoding RNA (HAGLROS) and prognosis of patients with colorectal cancer (CRC), as well as the roles and regulatory mechanism of HAGLROS in CRC development. The HAGLROS expression in CRC tissues and cells was detected. The correlation between HAGLROS expression and survival time of CRC patients was investigated. Moreover, HAGLROS was overexpressed and suppressed in HCT‐116 cells, followed by detection of cell viability, apoptosis, and the expression of apoptosis‐related proteins and autophagy markers. Furthermore, the association between HAGLROS and miR‐100 and the potential targets of miR‐100 were investigated. Besides, the regulatory relationship between HAGLROS and PI3K/AKT/mTOR pathway was elucidated. The results showed that HAGLROS was highly expressed in CRC tissues and cells. Highly expression of HAGLROS correlated with a shorter survival time of CRC patients. Moreover, knockdown of HAGLROS in HCT‐116 cells induced apoptosis by increasing the expression of Bax/Bcl‐2 ratio, cleaved‐caspase‐3, and cleaved‐caspase‐9, and inhibited autophagy by decreasing the expression of LC3II/LC3I and Beclin‐1 and increasing P62 expression. Furthermore, HAGLROS negatively regulated the expression of miR‐100, and HAGLROS controlled HCT‐116 cell apoptosis and autophagy through negatively regulation of miR‐100. Autophagy related 5 (ATG5) was verified as a functional target of miR‐100 and miR‐100 regulated HCT‐116 cell apoptosis and autophagy through targeting ATG5. Besides, HAGLROS overexpression activated phosphatidylinositol‐3‐kinase/protein kinase B/mammalian target of rapamycin (PI3K/Akt/mTOR) pathway. In conclusion, a highly expression of HAGLROS correlated with shorter survival time of CRC patients. Downregulation of HAGLROS may induce apoptosis and inhibit autophagy in CRC cells by regulation of miR‐100/ATG5 axis and PI3K/AKT/mTOR pathway.